Allan Steven Jacobson, Director at PTC THERAPEUTICS, INC. (PTCT), sold 37,800 shares at $51.41 ($1.9M) on 2020-04-20, disclosed to the SEC on 2020-04-21.
Open-market sale of $1.9M PTCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.16 | 2,100 | $105K | 5.5% |
| 2 | $50.58 | 8,147 | $412K | 21.4% |
| 3 | $50.58 | 8,147 | $412K | 21.4% |
| 4 | $51.41 | 9,653 | $496K | 25.8% |
| 5 | $51.41 | 9,653 | $496K | 25.8% |
| 6 | $52.16 | 100 |
| $5K |
| 0.3% |
| Total | $50.98 avg | 37,800 | $1.9M | 100% |
| Filing → |
| PTCT | SELL | 2025-09-02 | $167K | — | Filing → |
| PTCT | SELL | 2025-03-06 | $127K | — | Filing → |
| PTCT | SELL | 2024-01-24 | $274K | — | Filing → |